{"timestamp": 1771594768.3984447, "value": {"ticker": "GLMD", "company_name": "Galmed Pharmaceuticals Ltd.", "short_name": "Galmed Pharmaceuticals Ltd.", "sector": "Healthcare", "industry": "Biotechnology", "country": "Israel", "market_cap": 3757973, "float_shares": 5416220, "shares_outstanding": 6581390, "short_ratio": 0.71, "short_percent_of_float": 0.010299999, "shares_short": 55704, "shares_short_prior": 73076, "insider_percent_held": 0.00994, "institution_percent_held": 0.033940002, "total_cash": 19051000, "total_debt": 0, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 7.979, "book_value": 3.488, "price_to_book": 0.16370413, "operating_cashflow": -6278000, "free_cashflow": -4574250, "price": 0.571, "52w_high": 3.5, "52w_low": 0.55, "avg_volume": 543496, "avg_volume_10d": 72760, "full_time_employees": 3, "audit_risk": 0, "overall_risk": 0}}